PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ciclosporin - Dry eyes
PAD Profile : Ciclosporin - Dry eyes Important
Keywords :
Keratitis, NICE, Shared care
Brand Names Include :
Ikervis
Important Information :
0.1% ciclosporin (Ikervis)
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
- Dermatology indications
- Psoriatic arthritis
- Gastroenterology indications
- Dry eyes
- Neurology indications
- Uveitis
- Renal indications
- Rheumatology indications
Additional Documents
Type
Document
Review Date
Shared Care
01 July 2019
Shared Care
01 July 2019
Shared Care
01 July 2019
Committee Recommendations
Date
Committee Name
Narrative
06 July 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends Ciclosporin (Ikervis®) eye drops (1mg/ml) as a treatment option in line with NICE TA369 and it will be considered BLUE (with and information sheet) on the traffic light system
Associated BNF Codes
11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent